These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11850764)

  • 1. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.
    Pedrinelli R; Dell'Omo G; Di Bello V; Pontremoli R; Mariani M
    J Hum Hypertens; 2002 Feb; 16(2):79-89. PubMed ID: 11850764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary albumin and cardiovascular profile in the middle-aged population.
    Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
    Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absolute cardiovascular risk among nephrology patients].
    Hannedouche T; Bouiller M; Caillard S
    Nephrologie; 1998; 19(4):197-201. PubMed ID: 9675759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microalbuminuria, hypertension, and cardiovascular risk].
    Deferrari G; Pontremoli R
    Cardiologia; 1994 Dec; 39(12 Suppl 1):159-62. PubMed ID: 7634260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease.
    Pedrinelli R; Dell'Omo G; Penno G; Mariani M
    Vasc Med; 2001 Nov; 6(4):257-64. PubMed ID: 11958393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria: a useful marker of cardiovascular disease.
    Jarraya F; Lakhdar R; Kammoun K; Mahfoudh H; Drissa H; Kammoun S; Abid M; Hachicha J
    Iran J Kidney Dis; 2013 May; 7(3):178-86. PubMed ID: 23689147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment--a national study in Sweden.
    Journath G; Nilsson PM; Petersson U; Paradis BA; Theobald H; Erhardt L
    Blood Press; 2005; 14(3):144-50. PubMed ID: 16036494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria as a prognostic marker of cardiovascular diseases].
    Lisowska-Myjak B
    Pol Merkur Lekarski; 1997 Jul; 3(13):28-9. PubMed ID: 9432297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment].
    Koziolek MJ; Bramlage CP; Vasko R; Grupp C; Müller GA
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1681-5. PubMed ID: 19707964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity.
    Bianchi S; Bigazzi R; Amoroso A; Campese VM
    J Hum Hypertens; 2003 Jan; 17(1):13-20. PubMed ID: 12571612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microalbuminuria].
    Olsen MH; Ibsen H; Mogensen CE
    Ugeskr Laeger; 2009 Jun; 171(25):2097-100. PubMed ID: 19671389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
    Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria.
    Pontremoli R; Leoncini G; Viazzi F; Ratto E; Vaccaro V; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S112-4. PubMed ID: 16565232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
    J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.